Otros idiomas Immuron Limited Nasdaq

Acciones

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:01 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
2,17 ^USD	-3,12 %		-2,69 %	+15,73 %

05/06	Immuron Limited nombra directora a Jeannette Joughin	CI
31/05	Immuron Limited anuncia la dimisión de Roger Aston como director no ejecutivo	CI

Immuron Limited Appoints Jeannette Joughin as Director	05/06
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05/06
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05/06
Immuron Board Changes	31/05
Immuron CEO Steven Lydeamore to present at Peak Sky High	31/05
Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	31/05
Immuron Limited to Present at the Emerging Growth Conference	07/05
Immuron Director Resignation	03/05
Immuron Director Resignation	03/05
Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director	03/05
Immuron to host Live Virtual Event	15/04
Immuron Travelan® sales continued strong growth	10/04
Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	10/04
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10/04
Sector Update: Health Care Stocks Gain Late Afternoon	07/03
Sector Update: Health Care	07/03
Top Midday Gainers	07/03
Top Premarket Gainers	07/03
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07/03
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	07/03

No hay resultados para esta búsqueda